neoteric - agree wholly.
did some work on OCL recently and decided to get on board. i believe the price-to-operating cash flow of ~5x is extremely attractive, particularly given this is after their big R&D expense.
demand for their product will only grow, as State/Local Govt departments continue to "go digital".
agree it has been missed by analysts, the liquidity issue is probably a big factor in my opinion.
my only worry is the revenue model appears to be an annual license, rather than a subscription model. SaaS and subscription tend to go hand-in-hand, and the big boys are moving in that direction (Adobe, Oralce, Xero.....)
- Forums
- ASX - By Stock
- is anyone out there
neoteric - agree wholly.did some work on OCL recently and...
Featured News
Add OCL (ASX) to my watchlist
(20min delay)
|
|||||
Last
$17.52 |
Change
0.200(1.15%) |
Mkt cap ! $1.408B |
Open | High | Low | Value | Volume |
$17.38 | $17.70 | $17.38 | $1.311M | 74.89K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 124 | $17.51 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$17.66 | 737 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 7125 | 2.750 |
2 | 1356 | 2.710 |
2 | 1194 | 2.600 |
1 | 2997 | 2.510 |
2 | 44658 | 2.500 |
Price($) | Vol. | No. |
---|---|---|
2.780 | 3 | 1 |
2.790 | 3 | 1 |
2.800 | 5003 | 2 |
2.850 | 2206 | 1 |
2.950 | 354 | 1 |
Last trade - 16.10pm 25/11/2024 (20 minute delay) ? |
Featured News
OCL (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online